| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 RARA SCRT1 RARB ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF225 ZNF226 MLXIP ZNF232 ZNF236 ZNF658B ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZNF723 ZFP69B ZKSCAN4 ZNF548 ZNF582 ZNF426 NOTCH1 ZNF572 ZNF445 | 6.21e-30 | 1412 | 152 | 60 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 RARA SCRT1 RARB ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF225 ZNF226 MLXIP ZNF232 ZNF236 ZNF658B ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZNF723 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 3.67e-29 | 1459 | 152 | 60 | GO:0000977 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 RARA SCRT1 RARB ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF225 ZNF226 MLXIP ZNF232 ZNF236 ZNF658B ZNF251 ZNF12 ZNF16 ZNF23 SALL1 ZNF660 ZNF530 ZNF37A ZNF544 ZNF655 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF701 ZNF470 ZNF615 ZNF723 ZKSCAN4 ZNF763 ZNF548 ZNF426 NOTCH1 ZNF572 ZNF445 | 3.69e-22 | 1271 | 152 | 49 | GO:0000987 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 RARA SCRT1 RARB ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF225 ZNF226 MLXIP ZNF232 ZNF236 ZNF658B ZNF251 ZNF12 ZNF16 ZNF23 SALL1 ZNF660 ZNF530 ZNF37A ZNF544 ZNF655 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF701 ZNF470 ZNF615 ZNF723 ZKSCAN4 ZNF763 ZNF548 ZNF426 ZNF572 ZNF445 | 1.07e-21 | 1244 | 152 | 48 | GO:0000978 |
| Domain | zf-C2H2 | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.45e-49 | 693 | 147 | 62 | PF00096 |
| Domain | - | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF256 ZNF483 ZNF286B ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.75e-47 | 679 | 147 | 60 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF256 ZNF483 ZNF286B ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 6.42e-47 | 694 | 147 | 60 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.38e-46 | 775 | 147 | 62 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.61e-46 | 777 | 147 | 62 | PS00028 |
| Domain | Znf_C2H2 | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.39e-45 | 805 | 147 | 62 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.74e-45 | 808 | 147 | 62 | SM00355 |
| Domain | Znf_C2H2-like | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 1.23e-44 | 796 | 147 | 61 | IPR015880 |
| Domain | KRAB | ZNF765 ZNF383 ZNF135 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF429 ZNF300 ZNF233 ZNF223 ZNF225 ZNF226 ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF20 ZNF23 ZNF550 ZNF556 ZNF530 ZNF37A ZNF544 ZNF846 ZNF256 ZNF483 ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF445 | 5.24e-39 | 358 | 147 | 43 | PS50805 |
| Domain | KRAB | ZNF765 ZNF383 ZNF135 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF429 ZNF300 ZNF233 ZNF223 ZNF225 ZNF226 ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF20 ZNF23 ZNF550 ZNF556 ZNF530 ZNF37A ZNF544 ZNF846 ZNF256 ZNF483 ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF445 | 1.97e-38 | 369 | 147 | 43 | SM00349 |
| Domain | KRAB | ZNF765 ZNF383 ZNF135 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF429 ZNF300 ZNF233 ZNF223 ZNF225 ZNF226 ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF20 ZNF23 ZNF550 ZNF556 ZNF530 ZNF37A ZNF544 ZNF846 ZNF256 ZNF483 ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF445 | 2.21e-38 | 370 | 147 | 43 | IPR001909 |
| Domain | KRAB | ZNF765 ZNF383 ZNF135 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF429 ZNF300 ZNF233 ZNF223 ZNF225 ZNF226 ZNF251 ZNF563 ZNF10 ZNF599 ZNF12 ZNF20 ZNF550 ZNF556 ZNF530 ZNF37A ZNF544 ZNF846 ZNF256 ZNF483 ZNF808 ZNF264 ZNF578 ZNF749 ZNF701 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF445 | 1.24e-37 | 358 | 147 | 42 | PF01352 |
| Domain | zf-C2H2_6 | ZNF765 ZNF135 SCRT1 ZNF234 ZNF584 ZNF813 ZNF429 ZNF225 ZNF236 ZNF251 ZNF10 ZNF12 ZNF16 ZNF20 ZNF660 ZNF556 ZNF530 ZNF846 ZNF256 ZNF483 ZNF808 ZNF578 ZNF749 ZNF701 ZNF80 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 3.76e-29 | 314 | 147 | 34 | PF13912 |
| Domain | EGF_2 | STAB2 ADAM21 LAMC1 LAMC3 VWCE TMEFF1 CD93 FBLN2 TENM1 ADAM2 NOTCH1 EPHA3 | 1.28e-06 | 265 | 147 | 12 | PS01186 |
| Domain | zf-H2C2_2 | 3.47e-06 | 14 | 147 | 4 | PF13465 | |
| Domain | EGF | STAB2 LAMC1 LAMC3 VWCE TMEFF1 CD93 FBLN2 TENM1 ZNF578 NOTCH1 | 1.73e-05 | 235 | 147 | 10 | SM00181 |
| Domain | EGF-like_dom | STAB2 ADAM21 LAMC1 LAMC3 VWCE TMEFF1 CD93 FBLN2 TENM1 NOTCH1 | 2.85e-05 | 249 | 147 | 10 | IPR000742 |
| Domain | Growth_fac_rcpt_ | 3.31e-05 | 156 | 147 | 8 | IPR009030 | |
| Domain | EGF_1 | STAB2 ADAM21 LAMC1 LAMC3 VWCE TMEFF1 FBLN2 TENM1 ADAM2 NOTCH1 | 3.48e-05 | 255 | 147 | 10 | PS00022 |
| Domain | EGF-like_CS | STAB2 ADAM21 LAMC1 LAMC3 VWCE TMEFF1 CD93 FBLN2 TENM1 NOTCH1 | 4.24e-05 | 261 | 147 | 10 | IPR013032 |
| Domain | SCAN | 9.24e-05 | 58 | 147 | 5 | PF02023 | |
| Domain | SCAN_dom | 9.24e-05 | 58 | 147 | 5 | IPR003309 | |
| Domain | EGF_3 | 1.04e-04 | 235 | 147 | 9 | PS50026 | |
| Domain | Peptidase_M12B_N | 2.45e-04 | 39 | 147 | 4 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.45e-04 | 39 | 147 | 4 | PF01562 | |
| Domain | DISINTEGRIN_1 | 2.70e-04 | 40 | 147 | 4 | PS00427 | |
| Domain | Reprolysin | 2.70e-04 | 40 | 147 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 2.70e-04 | 40 | 147 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.70e-04 | 40 | 147 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 2.70e-04 | 40 | 147 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 2.97e-04 | 41 | 147 | 4 | IPR001762 | |
| Domain | Glycine_rcpt_A | 3.65e-04 | 4 | 147 | 2 | IPR008127 | |
| Domain | Retinoic_acid_rcpt | 3.65e-04 | 4 | 147 | 2 | IPR003078 | |
| Domain | KAZAL | 4.65e-04 | 46 | 147 | 4 | SM00280 | |
| Domain | KAZAL_2 | 6.40e-04 | 50 | 147 | 4 | PS51465 | |
| Domain | Kazal_dom | 6.91e-04 | 51 | 147 | 4 | IPR002350 | |
| Domain | RBD | 9.04e-04 | 6 | 147 | 2 | PF02196 | |
| Domain | SCAN | 9.85e-04 | 56 | 147 | 4 | SM00431 | |
| Domain | SCAN_BOX | 1.12e-03 | 58 | 147 | 4 | PS50804 | |
| Domain | Retrov_capsid_C | 1.20e-03 | 59 | 147 | 4 | IPR008916 | |
| Domain | RBD | 1.26e-03 | 7 | 147 | 2 | SM00455 | |
| Domain | RBD_dom | 1.26e-03 | 7 | 147 | 2 | IPR003116 | |
| Domain | RBD | 1.26e-03 | 7 | 147 | 2 | PS50898 | |
| Domain | TSP_1 | 1.53e-03 | 63 | 147 | 4 | PF00090 | |
| Domain | ZF_DAG_PE_1 | 1.62e-03 | 64 | 147 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 1.62e-03 | 64 | 147 | 4 | PS50081 | |
| Domain | EGF_LAM_2 | 1.66e-03 | 30 | 147 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 1.66e-03 | 30 | 147 | 3 | PS01248 | |
| Domain | SPARC_Ca_bdg | 1.67e-03 | 8 | 147 | 2 | PF10591 | |
| Domain | SPARC/Testican_Ca-bd-dom | 1.67e-03 | 8 | 147 | 2 | IPR019577 | |
| Domain | LAMININ_IVA | 1.67e-03 | 8 | 147 | 2 | PS51115 | |
| Domain | Laminin_B | 1.67e-03 | 8 | 147 | 2 | PF00052 | |
| Domain | LamB | 1.67e-03 | 8 | 147 | 2 | SM00281 | |
| Domain | Laminin_IV | 1.67e-03 | 8 | 147 | 2 | IPR000034 | |
| Domain | C1 | 1.72e-03 | 65 | 147 | 4 | SM00109 | |
| Domain | TSP1 | 1.72e-03 | 65 | 147 | 4 | SM00209 | |
| Domain | TSP1_rpt | 1.72e-03 | 65 | 147 | 4 | IPR000884 | |
| Domain | TSP1 | 1.72e-03 | 65 | 147 | 4 | PS50092 | |
| Domain | PE/DAG-bd | 1.82e-03 | 66 | 147 | 4 | IPR002219 | |
| Domain | EGF_Lam | 2.60e-03 | 35 | 147 | 3 | SM00180 | |
| Domain | EGF_CA | 2.80e-03 | 122 | 147 | 5 | SM00179 | |
| Domain | Kazal_2 | 2.82e-03 | 36 | 147 | 3 | PF07648 | |
| Domain | EGF-like_Ca-bd_dom | 3.00e-03 | 124 | 147 | 5 | IPR001881 | |
| Domain | ZnF_BED | 3.23e-03 | 11 | 147 | 2 | SM00614 | |
| Domain | Laminin_EGF | 3.29e-03 | 38 | 147 | 3 | IPR002049 | |
| Domain | MetalloPept_cat_dom | 3.83e-03 | 81 | 147 | 4 | IPR024079 | |
| Domain | - | 3.83e-03 | 81 | 147 | 4 | 3.40.390.10 | |
| Domain | Znf_BED | 3.86e-03 | 12 | 147 | 2 | IPR003656 | |
| Domain | Quinoprot_gluc/sorb_DH | 3.86e-03 | 12 | 147 | 2 | IPR011041 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 4.73e-03 | 138 | 147 | 5 | IPR001245 | |
| Domain | EGF_CA | 4.75e-03 | 86 | 147 | 4 | PF07645 | |
| Domain | Laminin_N | 6.87e-03 | 16 | 147 | 2 | IPR008211 | |
| Domain | Disintegrin_CS | 6.87e-03 | 16 | 147 | 2 | IPR018358 | |
| Domain | LAMININ_NTER | 6.87e-03 | 16 | 147 | 2 | PS51117 | |
| Domain | Laminin_N | 6.87e-03 | 16 | 147 | 2 | PF00055 | |
| Domain | LamNT | 6.87e-03 | 16 | 147 | 2 | SM00136 | |
| Domain | EGF_Ca-bd_CS | 7.25e-03 | 97 | 147 | 4 | IPR018097 | |
| Domain | TY | 7.74e-03 | 17 | 147 | 2 | SM00211 | |
| Domain | - | 7.74e-03 | 17 | 147 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 7.74e-03 | 17 | 147 | 2 | PS51162 | |
| Domain | Thyroglobulin_1 | 7.74e-03 | 17 | 147 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 7.74e-03 | 17 | 147 | 2 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 7.74e-03 | 17 | 147 | 2 | PS00484 | |
| Domain | EGF_CA | 7.78e-03 | 99 | 147 | 4 | PS01187 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED20 ZNF383 ZNF135 ZNF138 RARA RARB ZNF234 ZNF584 ZNF460 ZNF189 ZNF429 ZNF300 ZNF233 GPAM ZNF223 ZNF225 ZNF226 ZNF563 ZNF10 ZNF599 ZNF12 ZNF20 ZNF23 ZNF550 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF256 ZNF483 ZNF264 ZNF749 ZNF701 ZNF470 ZNF615 ZFP69B ZKSCAN4 BRD1 ZNF548 ZNF582 ZNF426 NOTCH1 ZNF445 | 2.90e-18 | 1387 | 108 | 45 | M734 |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | ZNF383 RARA RARB ZNF189 ZNF429 ZNF300 ZNF226 ZNF563 ZNF12 ZNF23 ZNF655 ZNF483 ZNF286B ZNF808 ZKSCAN4 BRD1 ZNF426 NOTCH1 ZNF445 | 5.23e-06 | 768 | 108 | 19 | MM14851 |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ZNF383 RARA RARB TAF1B ZNF189 ZNF429 ZNF300 ZNF226 NUP205 ZNF563 ZNF12 JARID2 ZNF23 ZNF655 ZNF483 ZNF286B ZNF808 ZKSCAN4 BRD1 ZNF426 NOTCH1 ZNF445 | 8.04e-06 | 1022 | 108 | 22 | MM15436 |
| Pathway | REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA | 6.90e-05 | 11 | 108 | 3 | M27184 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.71e-04 | 68 | 108 | 5 | M27303 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.18e-04 | 39 | 108 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.18e-04 | 39 | 108 | 4 | MM15165 | |
| Pubmed | ZNF383 ZNF460 ZNF813 ZNF563 ZNF20 ZNF550 ZNF655 ZNF264 ZNF749 ZNF701 ZNF615 ZNF445 | 3.19e-11 | 181 | 153 | 12 | 37372979 | |
| Pubmed | 3.37e-10 | 21 | 153 | 6 | 7865130 | ||
| Pubmed | Multiple genes encoding zinc finger domains are expressed in human T cells. | 4.42e-09 | 31 | 153 | 6 | 2288909 | |
| Pubmed | 2.27e-08 | 20 | 153 | 5 | 12743021 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | MED20 ZNF383 RARA RARB ZNF584 TAF1B ZNF407 ZNF226 MLXIP ZNF232 ZNF236 ZNF12 JARID2 ZNF23 ZNF35 ZNF556 ZNF451 BRD1 | 6.88e-08 | 877 | 153 | 18 | 20211142 |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 11245412 | ||
| Pubmed | KLF8 RARA ZNF429 ZNF300 ZNF236 CTDSP2 ZNF462 JARID2 SALL1 ZNF655 ZNF451 ZNF286B ZKSCAN4 ZNF426 ZNF445 | 3.11e-06 | 808 | 153 | 15 | 20412781 | |
| Pubmed | LRRC8E KLF8 ZNF138 ZNF813 ZNF629 ZNF236 ZNF658B ZNF251 ZNF749 ZNF701 ZNF615 | 5.53e-06 | 451 | 153 | 11 | 36168627 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | MED20 EEF1AKMT3 ZNF584 ZNF300 ZNF225 TMEFF1 ZNF16 ZNF23 ZNF660 ZNF530 ZNF544 KCNJ5-AS1 ZNF256 ZNF470 PLEKHM3 | 1.36e-05 | 915 | 153 | 15 | 32393512 |
| Pubmed | Congenital diaphragmatic hernia: comparison of animal models and relevance to the human situation. | 1.78e-05 | 12 | 153 | 3 | 19325248 | |
| Pubmed | Characterization of the glycinergic input to bipolar cells of the mouse retina. | 1.92e-05 | 2 | 153 | 2 | 16420443 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20047953 | ||
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 1.92e-05 | 2 | 153 | 2 | 29921692 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 25096573 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22826437 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 23834509 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 17018604 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 31395435 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 1330302 | ||
| Pubmed | EphA3 promotes the proliferation of NPC cells through negatively regulating the ability of FOG2. | 1.92e-05 | 2 | 153 | 2 | 32633364 | |
| Pubmed | Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. | 1.92e-05 | 2 | 153 | 2 | 15035987 | |
| Pubmed | B-Raf and Raf-1 are regulated by distinct autoregulatory mechanisms. | 1.92e-05 | 2 | 153 | 2 | 15710605 | |
| Pubmed | BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF. | 1.92e-05 | 2 | 153 | 2 | 23517740 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 24833708 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27835901 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 29511687 | ||
| Pubmed | Truncated RAF kinases drive resistance to MET inhibition in MET-addicted cancer cells. | 1.92e-05 | 2 | 153 | 2 | 25473895 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35501461 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 33249733 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21577205 | ||
| Pubmed | Essential, non-redundant roles of B-Raf and Raf-1 in Ras-driven skin tumorigenesis. | 1.92e-05 | 2 | 153 | 2 | 22733131 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 7644503 | ||
| Pubmed | Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy. | 1.92e-05 | 2 | 153 | 2 | 28904948 | |
| Pubmed | CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. | 1.92e-05 | 2 | 153 | 2 | 18794803 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 19959465 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35670653 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 35031788 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 21486794 | ||
| Pubmed | B-Raf and C-Raf are required for melanocyte stem cell self-maintenance. | 1.92e-05 | 2 | 153 | 2 | 23022482 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 22833462 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 18205709 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 9168777 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 1334013 | ||
| Pubmed | Regulation of Krüppel-like factor 8 by the NEDD4 E3 ubiquitin ligase. | 1.92e-05 | 2 | 153 | 2 | 30972179 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 15159591 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 33012268 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 30601638 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27431613 | ||
| Pubmed | RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation. | 1.92e-05 | 2 | 153 | 2 | 23680146 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 16172610 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 20978199 | ||
| Pubmed | Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. | 1.92e-05 | 2 | 153 | 2 | 25394321 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 11325826 | ||
| Pubmed | RAF inhibitors that evade paradoxical MAPK pathway activation. | 1.92e-05 | 2 | 153 | 2 | 26466569 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 26646323 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 27306217 | ||
| Pubmed | Biomarkers to detect membranous nephropathy in Chinese patients. | 1.92e-05 | 2 | 153 | 2 | 27634909 | |
| Pubmed | Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. | 1.92e-05 | 2 | 153 | 2 | 16364920 | |
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 26393352 | ||
| Pubmed | 1.92e-05 | 2 | 153 | 2 | 12009305 | ||
| Pubmed | 2.31e-05 | 13 | 153 | 3 | 19165826 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E ZNF765 ZNF460 ZNF189 ZNF813 ZNF629 LAMC1 ZNF407 PTK7 NUP205 ZNF462 ZNF12 ZNF16 ZNF655 ZNF451 ZNF808 ZNF525 | 2.40e-05 | 1203 | 153 | 17 | 29180619 |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.68e-05 | 79 | 153 | 5 | 18757743 | |
| Pubmed | 4.48e-05 | 16 | 153 | 3 | 30579834 | ||
| Pubmed | Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib. | 5.75e-05 | 3 | 153 | 2 | 24486585 | |
| Pubmed | RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth. | 5.75e-05 | 3 | 153 | 2 | 20130576 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 7607068 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 7607067 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 11172439 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 8383767 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 10454553 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 39392048 | ||
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 5.75e-05 | 3 | 153 | 2 | 1655807 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 22110129 | ||
| Pubmed | Mutation analysis of the BRAF, ARAF and RAF-1 genes in human colorectal adenocarcinomas. | 5.75e-05 | 3 | 153 | 2 | 14688025 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 22510884 | ||
| Pubmed | Expression of raf family proto-oncogenes in normal mouse tissues. | 5.75e-05 | 3 | 153 | 2 | 1690378 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 9659935 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 9207797 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 23969901 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 10100049 | ||
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 5.75e-05 | 3 | 153 | 2 | 1283441 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 17635919 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 36446525 | ||
| Pubmed | Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. | 5.75e-05 | 3 | 153 | 2 | 23352452 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 15528208 | ||
| Pubmed | Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF. | 5.75e-05 | 3 | 153 | 2 | 20141835 | |
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 5.75e-05 | 3 | 153 | 2 | 1655630 | |
| Pubmed | ERK and PDE4 cooperate to induce RAF isoform switching in melanoma. | 5.75e-05 | 3 | 153 | 2 | 21478863 | |
| Pubmed | Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis. | 5.75e-05 | 3 | 153 | 2 | 10704835 | |
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 5.75e-05 | 3 | 153 | 2 | 8136307 | |
| Pubmed | ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. | 5.75e-05 | 3 | 153 | 2 | 22926515 | |
| Pubmed | RAF1/BRAF dimerization integrates the signal from RAS to ERK and ROKα. | 5.75e-05 | 3 | 153 | 2 | 28270557 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 8027572 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 5.75e-05 | 3 | 153 | 2 | 8099268 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 18697739 | ||
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 22169110 | ||
| Pubmed | Diversity of glycine receptors in the mouse retina: localization of the alpha4 subunit. | 5.75e-05 | 3 | 153 | 2 | 17154252 | |
| Pubmed | 5.75e-05 | 3 | 153 | 2 | 17920294 | ||
| Interaction | TRIM28 interactions | RAF1 ZNF765 ZNF383 ZNF584 ZNF460 UBR4 ZNF813 ZNF223 ZNF226 NUP205 ZNF563 ZNF462 ZNF10 ZNF12 ZNF20 ZNF550 ZNF37A ZNF544 ZNF655 ZNF256 ZNF483 ZNF808 ZNF264 ZNF749 ZNF701 ELP2 ZNF615 NOTCH1 VCAM1 ZNF445 | 2.76e-07 | 1474 | 148 | 30 | int:TRIM28 |
| Interaction | NDEL1 interactions | 3.50e-06 | 164 | 148 | 9 | int:NDEL1 | |
| Interaction | ZNF460 interactions | 8.30e-06 | 138 | 148 | 8 | int:ZNF460 | |
| Interaction | ZNF232 interactions | 3.93e-05 | 52 | 148 | 5 | int:ZNF232 | |
| Interaction | ZSCAN21 interactions | 4.50e-05 | 128 | 148 | 7 | int:ZSCAN21 | |
| Interaction | KCP interactions | 5.36e-05 | 2 | 148 | 2 | int:KCP | |
| Interaction | ZNF467 interactions | 5.42e-05 | 179 | 148 | 8 | int:ZNF467 | |
| Interaction | NOL4 interactions | 6.69e-05 | 58 | 148 | 5 | int:NOL4 | |
| Interaction | CDR2L interactions | 7.20e-05 | 95 | 148 | 6 | int:CDR2L | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | ZNF765 ZNF383 ZNF135 ZNF234 ZNF584 ZNF460 ZNF813 ZNF233 ZNF223 ZNF225 PLEKHG2 ZNF226 ZNF599 ZNF550 ZNF530 ZNF544 ZNF256 ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF470 ZNF615 ZNF548 ZNF582 | 3.96e-15 | 1192 | 153 | 27 | chr19q13 |
| Cytoband | 19q13.43 | ZNF584 ZNF550 ZNF530 ZNF544 ZNF256 ZNF749 ZNF470 ZNF548 ZNF582 | 1.64e-11 | 87 | 153 | 9 | 19q13.43 |
| Cytoband | 3p21.32 | 1.10e-04 | 5 | 153 | 2 | 3p21.32 | |
| Cytoband | 19p13.2 | 1.26e-04 | 229 | 153 | 6 | 19p13.2 | |
| Cytoband | 19q13.41 | 1.40e-04 | 78 | 153 | 4 | 19q13.41 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q31 | 1.18e-03 | 137 | 153 | 4 | chr9q31 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF765 ZNF383 ZNF135 KLF8 ZNF138 SCRT1 ZNF234 ZNF584 ZNF460 ZNF189 ZNF813 ZNF629 ZNF429 ZNF300 ZNF407 ZNF233 ZNF223 ZNF225 ZNF226 ZNF232 ZNF236 ZNF251 ZFPM2 ZNF563 ZNF462 ZNF10 ZNF599 ZNF12 ZNF16 ZNF20 ZNF23 SALL1 ZNF550 ZNF35 ZNF660 ZNF556 ZNF530 ZNF37A ZNF544 ZNF655 ZNF846 ZNF451 ZNF256 ZNF483 ZNF286B ZNF808 ZNF525 ZNF264 ZNF578 ZNF749 ZNF701 ZNF80 ZNF470 ZNF615 ZFP69B ZKSCAN4 ZNF763 ZNF548 ZNF582 ZNF426 ZNF572 ZNF445 | 2.30e-51 | 718 | 132 | 62 | 28 |
| GeneFamily | Mitogen-activated protein kinase kinase kinases|RAF family | 5.21e-04 | 5 | 132 | 2 | 1157 | |
| GeneFamily | Glycine receptors | 5.21e-04 | 5 | 132 | 2 | 868 | |
| GeneFamily | SPARC family | 1.44e-03 | 8 | 132 | 2 | 1278 | |
| GeneFamily | Laminin subunits | 3.33e-03 | 12 | 132 | 2 | 626 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | ADAM21 ZNF189 DYNLT3 TSPAN2 TMEFF1 ZNF451 ZNF701 ZNF582 ZNF426 ZMYM6 | 2.18e-07 | 196 | 151 | 10 | M7124 |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.84e-06 | 167 | 153 | 7 | 063ec29b32e40aaa138a691da3a79ee8eef0c2be | |
| ToppCell | ASK452-Epithelial-Secretory|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.61e-06 | 176 | 153 | 7 | dd334c8a8a31dc26b2d558df0ef6bed6dc1a6610 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 179 | 153 | 7 | d56fa2a0b119d51a8d41b00fbbd7dfddefeb279c | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 179 | 153 | 7 | e0542694fa79d67f67be6f85b4fa6d18f7523253 | |
| ToppCell | facs-GAT-Fat-18m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-06 | 179 | 153 | 7 | 83343b68977969c7978acd930a66fc7c44df6a15 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.02e-06 | 180 | 153 | 7 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 188 | 153 | 7 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 188 | 153 | 7 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 188 | 153 | 7 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 188 | 153 | 7 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-06 | 188 | 153 | 7 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-06 | 192 | 153 | 7 | dc40ef2341e5d6a6d479f140e023fe1bf687928d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.79e-06 | 193 | 153 | 7 | 2189da4b727e25e62669d7b9257f06493be21a27 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.79e-06 | 193 | 153 | 7 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.85e-06 | 199 | 153 | 7 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | a9cdddc4e985dae59521e557479c24fcc2ac727d | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6--L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 33b9199e0dfc267e2cea20b82d1c167f8adcc635 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 107854f4855fc99c9f7e737eb246f0d868e6c5fd | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)-ADGRG6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.05e-06 | 200 | 153 | 7 | 9719fabddc34051949468a7520289e3c750de4f8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.44e-05 | 152 | 153 | 6 | 5adcdf93fd3ca066402aaaf308c363e4648f871d | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-05 | 166 | 153 | 6 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 169 | 153 | 6 | 1d5ce2c97f7ef7bdc9f861938077a9aa31d84db6 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.63e-05 | 169 | 153 | 6 | 58098f8801ca941aeddafb47e88ab0df8b9edb57 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 170 | 153 | 6 | 84d49a1f2989d98bd0acf9ec2d59f1042fc0f55b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.72e-05 | 170 | 153 | 6 | 417b77c12a7982b1ce4b4bc57f30335d261220f5 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_KRT17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.90e-05 | 172 | 153 | 6 | adc09c4d1b63fe84150516beb692db1e7f7ac980 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.41e-05 | 177 | 153 | 6 | 16197068260fc062bf8b730a51a199887ea580b9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.41e-05 | 177 | 153 | 6 | bde307e67ad8e48a5ff4c0827015f4688f6b3e46 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.51e-05 | 178 | 153 | 6 | 9d575902d3dbe33437c9d4200df093a741269803 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 179 | 153 | 6 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.63e-05 | 179 | 153 | 6 | 7954c0026754ab869b88ab7feb13c2f27d6e272d | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.63e-05 | 179 | 153 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 181 | 153 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 181 | 153 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | mild-B_cell|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.10e-05 | 183 | 153 | 6 | 175aaf8fbbff52eab87d78a49d5ab02cd489c438 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-5_PVALB_TRIM67|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.23e-05 | 184 | 153 | 6 | 7f6c8912677764d438ab0555faca344d74c2f483 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.23e-05 | 184 | 153 | 6 | 8ed22b1af04a711203293e7a8b3df6fb9222fad5 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 186 | 153 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.49e-05 | 186 | 153 | 6 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.49e-05 | 186 | 153 | 6 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-05 | 186 | 153 | 6 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-05 | 187 | 153 | 6 | e93cad16a087d1443cbf4e1690dc1b35d7a84c41 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.77e-05 | 188 | 153 | 6 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.91e-05 | 189 | 153 | 6 | 06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 190 | 153 | 6 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 190 | 153 | 6 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 190 | 153 | 6 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.20e-05 | 191 | 153 | 6 | b9ae5af426e7a1f2652a47700bb168371bd2dec6 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Vein|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.36e-05 | 192 | 153 | 6 | 52acaecd3703166f5ce3b328aff7c82bd142fee4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.36e-05 | 192 | 153 | 6 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 193 | 153 | 6 | c7e9e6e4bf5e07c9cbdf1aa7c8828f4b2500e3ff | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 193 | 153 | 6 | 010717ca052b6c8a525a43aaeffddea0d1113e63 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.51e-05 | 193 | 153 | 6 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.51e-05 | 193 | 153 | 6 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-05 | 194 | 153 | 6 | 83863da11dfbe59b2d0a2c08db40b537c150588c | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.67e-05 | 194 | 153 | 6 | b111d10c99d7ff7eb261cd7786cd9d9a549049b1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.67e-05 | 194 | 153 | 6 | 1bcb3fafd498614f7bac2b1c9b7de56e39110f65 | |
| ToppCell | proximal-Hematologic-Natural_Killer_T-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.84e-05 | 195 | 153 | 6 | 4d7c2c4d0130c2d46877ff6dd4584525d8f74daf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius-36|World / Primary Cells by Cluster | 5.84e-05 | 195 | 153 | 6 | bc76a0586cc78f013cb96a2444e63e3c5daa3bc7 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Cajal_Retzius|World / Primary Cells by Cluster | 5.84e-05 | 195 | 153 | 6 | 424d8e2bc7f7e68f74219de06dbbb671c8b4c24c | |
| ToppCell | proximal-3-Hematologic-Natural_Killer_T|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.84e-05 | 195 | 153 | 6 | 93093545bb23d2619ace029a52cffa1f673a0c2a | |
| ToppCell | proximal-Hematologic-Natural_Killer_T|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.84e-05 | 195 | 153 | 6 | 3944e4800f5d904d4efa401ce8913ec0e0781211 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.01e-05 | 196 | 153 | 6 | a20a56d8997d6db2a10046c8801c619a379de83c | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.18e-05 | 197 | 153 | 6 | ad4a3b5da2190be9495382a2952991e1de9f190d | |
| ToppCell | medial-Endothelial-Artery|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | 341c0be18bec66f4cc8bda232dce54edb34b9cda | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | bd9090c13a38a35d50f676fdf11b68eec1340bd3 | |
| ToppCell | medial-2-Endothelial-Artery|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | 53c17c0493f82351a039bc64def191311e0f4951 | |
| ToppCell | distal-Endothelial-Bronchial_Vessel_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | ddd6cad854d889d58c1e6bbcdfd96edce4fc9694 | |
| ToppCell | medial-Endothelial-Artery-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.53e-05 | 199 | 153 | 6 | c455f5a2802f2ec6f0e24266de1aaf3203ca8c78 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-05 | 200 | 153 | 6 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 6.71e-05 | 200 | 153 | 6 | 5ad3ea1cf1fcd4100966c5517bc7ed0a1af54317 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 147 | 153 | 5 | 3ed5b020ce1f1277917d79ef1f7da53fa474e8db | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 151 | 153 | 5 | 29d91a7d1470121af45fb8bb35175f2acced4551 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.75e-04 | 151 | 153 | 5 | 9ebfbdccc9656fce8990d06622f225009633f07c | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri-Peri_Kcnj8|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 155 | 153 | 5 | ced64e26962c5c6e6d539f361fe57ab0b399e999 | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 155 | 153 | 5 | 0f24ef6486aef354f0911c06932cb01d1a0525ac | |
| ToppCell | primary_visual_cortex-Non-neuronal-pericyte_cell-Peri|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.97e-04 | 155 | 153 | 5 | d8b5145258f075b15080f8739f537f48dd22225e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.03e-04 | 156 | 153 | 5 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-cortical_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 2.16e-04 | 158 | 153 | 5 | 1f94622186d8329357fa06785e03eeacf29ab1ce | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 158 | 153 | 5 | f41ee21e5888359d817be1e3a902c132cb68e350 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 158 | 153 | 5 | d689feb7f612aef170da76fcf14abf2dd589082b | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-04 | 158 | 153 | 5 | 829ff3df46f173f2ff1c435e9bce35425e603b42 | |
| ToppCell | NS-critical-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.29e-04 | 160 | 153 | 5 | c61869d9dbba250270e59366e15af204e5b4395d | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Cajal-Retzius|3_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.42e-04 | 162 | 153 | 5 | 1f589a763f3fd4e1e612809ef3903879d47dc1d8 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 162 | 153 | 5 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | COVID-CD8-memory_CD4|COVID / Condition, Cell_class and T cell subcluster | 2.42e-04 | 162 | 153 | 5 | 22b2a32217d357146c117e618813d451510a1801 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Cajal-Retzius|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.49e-04 | 163 | 153 | 5 | c1484e4de8b10e2f5fb14a7c02b2a015ffe0305e | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.49e-04 | 163 | 153 | 5 | 0ab043b68e8739adcedda01165a3758cd0d22728 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-04 | 164 | 153 | 5 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-04 | 166 | 153 | 5 | 9adceb746e67e955fd8b3e0984f4eed44b64a270 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-04 | 166 | 153 | 5 | c8fd241088de27c6e741a5dfee3cd770183b6bcb | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.87e-04 | 168 | 153 | 5 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-04 | 168 | 153 | 5 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.03e-04 | 170 | 153 | 5 | 55fe16d98ea284d05fb899888e4569c685644c7b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-04 | 172 | 153 | 5 | cecfe5cf20f317ea01b4604789e07a14481c4cd6 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.19e-04 | 172 | 153 | 5 | eb199c279fe8a2551121db37e9556893197d33ff | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.19e-04 | 172 | 153 | 5 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 3.19e-04 | 172 | 153 | 5 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| Disease | Noonan syndrome with multiple lentigines | 6.31e-05 | 3 | 136 | 2 | cv:C0175704 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 1.26e-04 | 4 | 136 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 1.26e-04 | 4 | 136 | 2 | C0751925 | |
| Disease | Sciatic Neuropathy | 1.26e-04 | 4 | 136 | 2 | C0149940 | |
| Disease | Lesion of Sciatic Nerve | 1.26e-04 | 4 | 136 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 1.26e-04 | 4 | 136 | 2 | C0242013 | |
| Disease | scoliosis (implicated_via_orthology) | 2.09e-04 | 5 | 136 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Leopard Syndrome 1 | 3.13e-04 | 6 | 136 | 2 | C4551484 | |
| Disease | Pilomyxoid astrocytoma | 4.36e-04 | 7 | 136 | 2 | C1519086 | |
| Disease | testican-3 measurement | 4.36e-04 | 7 | 136 | 2 | EFO_0802124 | |
| Disease | factor VIII measurement, venous thromboembolism | 5.16e-04 | 34 | 136 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | acetoacetate measurement | 5.80e-04 | 8 | 136 | 2 | EFO_0010111 | |
| Disease | cerebrospinal fluid biomarker measurement, t-tau measurement | 7.43e-04 | 9 | 136 | 2 | EFO_0004760, EFO_0006794 | |
| Disease | Noonan syndrome | 7.43e-04 | 9 | 136 | 2 | cv:C0028326 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 9.64e-04 | 42 | 136 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA | 1.13e-03 | 11 | 136 | 2 | 146110 | |
| Disease | Noonan Syndrome 1 | 1.13e-03 | 11 | 136 | 2 | C4551602 | |
| Disease | Congenital Abnormality | 1.13e-03 | 11 | 136 | 2 | C0000768 | |
| Disease | Hypogonadotropic hypogonadism 7 with or without anosmia | 1.13e-03 | 11 | 136 | 2 | cv:C0342384 | |
| Disease | Turner Syndrome, Male | 1.13e-03 | 11 | 136 | 2 | C0041409 | |
| Disease | Female Pseudo-Turner Syndrome | 1.13e-03 | 11 | 136 | 2 | C1527404 | |
| Disease | Colorectal Carcinoma | 1.58e-03 | 702 | 136 | 10 | C0009402 | |
| Disease | C-X-C motif chemokine 11 measurement | 1.85e-03 | 14 | 136 | 2 | EFO_0008057 | |
| Disease | apolipoprotein A 1 measurement | SPINK8 RARB THSD7A TMPRSS11E LAMC1 GPAM MLXIP ZFPM2 NUP205 ZNF483 TANGO6 | 1.95e-03 | 848 | 136 | 11 | EFO_0004614 |
| Disease | RASopathy | 2.13e-03 | 15 | 136 | 2 | cv:C5555857 | |
| Disease | vascular endothelial growth factor measurement | 2.22e-03 | 56 | 136 | 3 | EFO_0004762 | |
| Disease | Uremia | 2.74e-03 | 17 | 136 | 2 | C0041948 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 3.07e-03 | 18 | 136 | 2 | C0342384 | |
| Disease | Noonan-Like Syndrome With Loose Anagen Hair | 3.43e-03 | 19 | 136 | 2 | C3501846 | |
| Disease | Noonan syndrome-like disorder with loose anagen hair | 3.43e-03 | 19 | 136 | 2 | C1843181 | |
| Disease | Cardio-facio-cutaneous syndrome | 3.43e-03 | 19 | 136 | 2 | C1275081 | |
| Disease | Costello syndrome (disorder) | 3.43e-03 | 19 | 136 | 2 | C0587248 | |
| Disease | chronic kidney disease (is_marker_for) | 3.79e-03 | 20 | 136 | 2 | DOID:784 (is_marker_for) | |
| Disease | prostate adenocarcinoma (is_implicated_in) | 3.79e-03 | 20 | 136 | 2 | DOID:2526 (is_implicated_in) | |
| Disease | venous thromboembolism, plasminogen activator inhibitor 1 measurement | 4.18e-03 | 21 | 136 | 2 | EFO_0004286, EFO_0004792 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 4.18e-03 | 228 | 136 | 5 | EFO_0003948, MONDO_0004975 | |
| Disease | LEOPARD Syndrome | 4.59e-03 | 22 | 136 | 2 | C0175704 | |
| Disease | age at voice drop | 4.59e-03 | 22 | 136 | 2 | EFO_0007888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CQTCGYKFHQRCSTE | 261 | P15056 | |
| CYTAFHVTCAQKAGL | 346 | O95696 | |
| NGTTYLKCHISDVFC | 546 | Q9UKJ8 | |
| CYSHLNSKTDVSGNC | 511 | Q99965 | |
| DAYTCANCSAFVHKG | 1816 | Q12802 | |
| CVGTACYTAHSGKLS | 31 | Q9NPY3 | |
| SYSEKSQFCFCGHVL | 26 | Q96AZ1 | |
| YLGCNHSTTILFCKA | 226 | P54107 | |
| QTCGYKFHEHCSTKV | 166 | P04049 | |
| TCVVQHFKSGVYTET | 31 | A4D1S5 | |
| CQDKSSGYHYGVSAC | 91 | P10276 | |
| CQDKSSGYHYGVSAC | 91 | P10826 | |
| CTKHYNTGKFTCIEV | 231 | O75311 | |
| CAHYCFSLLKVNGSS | 526 | Q92621 | |
| LTFCGSNVISHFYCD | 166 | Q8NH50 | |
| NTCTAHICAIVFSYT | 241 | Q8NGI2 | |
| HYGSCKDGVATFTCL | 576 | P46531 | |
| CEKSSEGYSCVSVHF | 366 | P46934 | |
| TVISNCSDGKLCSSY | 246 | Q6W5P4 | |
| CTHCLQGAVTTDYAA | 296 | Q86U10 | |
| ICGSDQVTYSSDCHL | 61 | P0C7L1 | |
| TCESVLSSAVYTHGC | 76 | Q8TAV5 | |
| KCTVCSYTADSVINF | 336 | Q8WW38 | |
| ICVTGKSNFQSYSCV | 86 | Q9NRM6 | |
| KQCSCTLHSGAYKAT | 216 | Q8IY33 | |
| CVNTLGSFHCYKALT | 736 | P98095 | |
| SHSGYQFASCSKDCT | 101 | Q969U6 | |
| YTVTSVSCCHGNTLL | 666 | Q86SG6 | |
| CDFAGCSKVYTKSSH | 276 | O95600 | |
| SEVTGYASFCCNHTK | 291 | Q6NSJ5 | |
| CASHLTVVALCYGTT | 241 | O95006 | |
| FATSHVYSCSLCSQK | 666 | Q6ZWE6 | |
| DSCESNHNITCKVGY | 876 | P56199 | |
| ISQHAKYTCSFCGKT | 31 | P61513 | |
| GYTLSYKAQSSCCHF | 66 | Q96JZ2 | |
| KSFGYSSVVCVCNAT | 46 | P04062 | |
| TCQTYSFGKTSSCHL | 106 | Q9HAP2 | |
| HCTKTCGSSGYQLRT | 916 | O15072 | |
| SCKTVAGTFNTVHYG | 751 | Q9P2N4 | |
| TFYHVSCEINTKGTT | 731 | Q5JSL3 | |
| SSGQTKVFSQCVTHC | 186 | P30968 | |
| AAHYQLVYTCKVCGT | 66 | Q5SXM8 | |
| SCVFHQGCYVKDLSR | 191 | O14595 | |
| VHCKNSESVYSGCLH | 101 | Q9NSG2 | |
| SCKTFCHYVNAINTA | 1181 | Q6ZUT9 | |
| SGYSFKQCSHQISAC | 96 | P03951 | |
| AHCKEIFTGVEYSSC | 926 | P29320 | |
| KCSHYLFSEEITSGC | 101 | P31785 | |
| YSKHASTTSCCQYDL | 76 | P0DP58 | |
| VTCAVVQKSAYGFHT | 66 | P51808 | |
| SARTYCYKQEGCHTA | 171 | Q8NEP7 | |
| YCVQTGVTGVTKSCH | 76 | P11047 | |
| CYHSKGVCSVSFSAT | 1466 | Q05BV3 | |
| HGYEIFCVTCNSSKT | 566 | Q6IA86 | |
| CCYKTNSHGETVKTL | 441 | Q5T890 | |
| CGKTFACQSALDIHY | 1006 | Q9NSC2 | |
| YNGKCQAVYTSSHCE | 346 | Q6ZN68 | |
| HYNCTTYECVKTDEG | 2211 | Q3ZCN5 | |
| VNTTNCHKCLLSGTY | 26 | Q9BZA8 | |
| VSKVCCGYSVSETVH | 1016 | Q92833 | |
| QGTFCVDCETYHTAA | 36 | Q9H944 | |
| SFGNEHSYLCTATCE | 86 | P19320 | |
| ENEHSYLCTVTCGHK | 376 | P19320 | |
| HACGECGKTYATSSN | 191 | Q9BWW7 | |
| SYCSETKTCHCEEGY | 1526 | Q9UPZ6 | |
| EISQHTKYTCSFCGK | 31 | A6NKH3 | |
| EGKYYCTSCHNVTER | 26 | Q53T94 | |
| FCSSVIYVIFGSCHQ | 131 | Q96RN1 | |
| LHFQGSCSYVLAKDC | 1231 | Q6ZWJ8 | |
| CTKHYNTGKFTCIEA | 226 | P23415 | |
| CQTFYQVCHETVGKF | 636 | Q9HCL2 | |
| FCETSHTLCSGYQTD | 76 | Q9UKZ4 | |
| VAICTLSFCIYKHNG | 1411 | Q13018 | |
| KTGSVTTTYCCNQDH | 91 | P36897 | |
| GSDISKTCCFQYSHK | 26 | Q9Y258 | |
| ECGKTFSQKSYLACH | 331 | Q8N782 | |
| CSVCGKGFSHSYVLI | 246 | Q7Z3I7 | |
| YECHECGKTFTQKSA | 271 | P17032 | |
| NKTETDSYLNHCCGT | 166 | Q9UL52 | |
| QQTHTGEKLYTCSEC | 391 | Q8N8J6 | |
| QYVIKCGTCTKAFHD | 786 | Q9Y4E5 | |
| CGKAFTCSSYLLIHQ | 451 | P13682 | |
| CNYCGKTFSVSSTLI | 206 | O75820 | |
| IKCSGCHSYQESTKQ | 381 | Q9UPT9 | |
| ECGKTFCLNSSFTQH | 371 | Q96NL3 | |
| YECSECGKAFTHHSV | 451 | Q96NL3 | |
| CSQCGKAFTHYSTYV | 366 | Q14592 | |
| YDGKECTETFISHSC | 171 | P17024 | |
| YVCKECGKAFSNSSH | 226 | Q147U1 | |
| CGKAFSCSSYLSQHQ | 231 | Q8NA42 | |
| ECGKSFSYKSSLTCH | 291 | Q96N58 | |
| CGKSFCYISALHIHQ | 181 | Q9UK11 | |
| YVCSECGKAFLTQAH | 556 | O43361 | |
| YECSQCGKAFRQSTH | 466 | P52742 | |
| YKCEVCGKAFHQSSI | 166 | P52744 | |
| YKCEECGKAFSQSSH | 341 | P0DPD5 | |
| YECSECGKSFIHSSS | 351 | Q9Y2P7 | |
| YECGECGKSFTHSST | 491 | Q9Y2P7 | |
| RYECSQCGKLFTHSS | 146 | Q9HAH1 | |
| YTCSECGKSFSGKSH | 106 | Q6AZW8 | |
| NSIGSYKCSCRTGFH | 196 | Q96DN2 | |
| YCFTKQSVSHIRSLC | 486 | Q9C0B7 | |
| ECGKSFSYKSSLTCH | 291 | Q8N4W9 | |
| YECIECGKAFSQSAH | 256 | Q6ECI4 | |
| FCHIHATCEYSNGTA | 836 | Q8WWQ8 | |
| CGKTFSQTYSLTCHR | 276 | Q6ZN06 | |
| CGSDGHTYSFQCKLE | 151 | Q9BQ16 | |
| CGKSFCYISALHIHQ | 181 | Q14588 | |
| YTCGECGKHFSQASS | 596 | Q14588 | |
| YACKECGKTFSHRSQ | 311 | Q96NG8 | |
| CGKSFCYSSALRIHQ | 181 | Q9UK10 | |
| QGVHTGEKSYICTVC | 466 | Q9NYT6 | |
| YECHDCGKSFSQSSA | 461 | P21506 | |
| YECTECGKTFIKSTH | 231 | O43296 | |
| HTIEYCLGCISNTAS | 726 | Q9HBG4 | |
| SECGKTFSYHSVFIQ | 136 | P51504 | |
| YECKQCGKALSHSSS | 421 | Q8TA94 | |
| YECTQCGKAFHRSTY | 371 | Q7Z398 | |
| SYKCDVCGKIFHQSS | 211 | Q8N720 | |
| KCTVCGSDFCHTSYL | 331 | Q8N720 | |
| YCHECGKSFAQSSGL | 321 | Q969J2 | |
| QSLHTVGVSFKCSDC | 476 | P59923 | |
| PCHCSVYGKAFSQSS | 621 | Q9BRH9 | |
| YHKTGSTQLFCSTRC | 106 | O95789 | |
| CNVCSKTFSHSTYLT | 421 | Q9UJL9 | |
| CTHCGKSFSQSYELV | 466 | Q6NX49 | |
| CEECGKAFNHYSTLT | 231 | Q86V71 | |
| NCEECGKVFTYSSTL | 426 | Q86V71 | |
| YKCETCGKGFSQSSH | 536 | A6NK53 | |
| ECGKTFTCSYSFVEH | 201 | Q8NEK5 | |
| HVCNVCGKAFSYSSV | 461 | P17020 | |
| YTCVECGKGFSQSSH | 601 | P17020 | |
| CKHCSYSNRSVVGVL | 1116 | Q96JM2 | |
| HECSECGKTFIYNSH | 276 | Q9UNY5 | |
| YTCSNCGKSFSHSSS | 551 | Q8TF39 | |
| THTGVKAFSCSVCNA | 1016 | Q9UL36 | |
| CGKTFSQTYYLTCHR | 276 | Q7L2R6 | |
| ECGKTFSQKSYLTCH | 331 | Q7L2R6 | |
| AVLVTTFHKYSCQEG | 11 | P29034 | |
| KSDAGTYFCQTVEHS | 646 | O15041 | |
| YKGHIFCCNLSVSES | 356 | Q9H7P9 | |
| YECSECGKSFSHSTN | 351 | Q6P9A1 | |
| YECSECGKTFSQSTH | 411 | P0CG31 | |
| YVCHDCGKTFSQKSA | 381 | P17014 | |
| YTCNECGKTFSHNSA | 336 | Q9NV72 | |
| CVECGKSFSYSSHYI | 226 | P17027 | |
| CLLCGKSFYTESNLH | 1446 | Q9C0G0 | |
| TLITFHSTFQCCGKE | 141 | O60636 | |
| CESGYTGQHCEKTDF | 301 | Q8IYR6 | |
| ICEYKGHFQTVASCV | 271 | Q8NA23 | |
| SFCSSSGYIQEKCVI | 981 | Q9C0I4 | |
| LLSSKTYICSHCGES | 656 | Q9UEG4 | |
| YECQQCGKAFHSSSS | 256 | Q0D2J5 | |
| HTSSTKCYGCASAVT | 3866 | Q5T4S7 | |
| RYTCIAGNSCNIKHT | 661 | Q13308 | |
| ETAHVCNECGKAFSY | 211 | Q8IVC4 | |
| SYECTECGKAFKHSS | 381 | Q8IVC4 | |
| CSHCGKSFINESYLQ | 226 | Q9BUY5 | |
| YECKQCGKAFSHSSS | 476 | Q9BUY5 | |
| YICTECGKAFSQKSH | 521 | Q96RE9 | |
| VNSCYYGNTVTLHCT | 176 | Q12836 | |
| SVCGSDGHTYSSVCK | 146 | Q92563 | |
| YECNECGKTFSQRTH | 586 | Q4V348 | |
| FCYGHSKVCASTAQF | 481 | Q9Y6N6 | |
| SINKTCSHYECAFLG | 246 | Q13508 |